Skip to main content
Premium Trial:

Request an Annual Quote

Venter to Retire From Human Longevity

Craig Venter is retiring from Human Longevity and will be returning to the J. Craig Venter Institute, the San Diego Union-Tribune reports.

Venter launched Human Longevity in 2014 to bring together various omic data types with clinical information to study and develop diagnostics and treatments for aging-linked diseases. At the time, Venter said the for-profit company would "change the way medicine is practiced" and would lead "a shift to a more preventive, genomic-based medicine model."

The Union-Tribune notes that Venter had been re-appointed CEO of Human Longevity, replacing Cynthia Collins, who along with others, was out following a shakeup of the management team.

Venter announced his plans to retire from the company, last week in a tweet in which he said he'd be moving back to JCVI "to continue my work." The non-profit JCVI was founded in 1992 as the Institute for Genomic Research and became the J. Craig Venter Institute in 2006 after a series of consolidations.